Are IgM-enriched immunoglobulins an effective adjuvant in septic VLBW infants?
Authors:
- Letizia CapassoLCLetizia Capasso
- Angela Carla BorrelliABAngela Carla Borrelli
- Claudia ParrellaCPClaudia Parrella
- Silvia LamaSLSilvia Lama
- Teresa FerraraTFTeresa Ferrara
- Clara CoppolaCCClara Coppola
- Maria Rosaria CataniaMCMaria Rosaria Catania
- Vita Dora IulaVIVita Dora Iula
- Francesco RaimondiFRFrancesco Raimondi
Open Access
- 7 October 2013
- journal article
- Published by Springer Nature in Italian Journal of Pediatrics
- Vol. 39 (1) , 63
Abstract
To investigate the effectiveness of IgM-enriched immunoglobulins (IgM-eIVIG) in reducing short-term mortality of neonates with proven late-onset sepsis. All VLBW infants from January 2008 to December 2012 with positive blood culture beyond 72 hours of life were enrolled in a retrospective cohort study. Newborns born after June 2010 were treated with IgM-eIVIG, 250 mg/kg/day iv for three days in addition to standard antibiotic regimen and compared to an historical cohort born before June 2010, receiving antimicrobial regimen alone. Short-term mortality (i.e. death within 7 and 21 days from treatment) was the primary outcome. Secondary outcomes were: total mortality, intraventricular hemorrhage, necrotizing enterocolitis, periventricular leukomalacia, bronchopulmonary dysplasia at discharge. 79 neonates (40 cases) were enrolled. No difference in birth weight, gestational age or SNAP II score (disease severity score) were found. Significantly reduced short-term mortality was found in treated infants (22% vs 46%; p = 0.005) considering all microbial aetiologies and the subgroup affected by Candida spp. Secondary outcomes were not different between groups. This hypothesis-generator study shows that IgM-eIVIG is an effective adjuvant therapy in VLBW infants with proven sepsis. Randomized controlled trials are warranted to confirm this pilot observation.Keywords
This publication has 16 references indexed in Scilit:
- Intravenous immunoglobulin for suspected or proven infection in neonates2013
- Neonatal sepsis: A difficult diagnostic challengeClinical Biochemistry, 2011
- Adjunctive Immunologic Interventions in Neonatal SepsisClinics in Perinatology, 2010
- EFFECTS OF IGM-ENRICHED SOLUTION ON POLYMORPHONUCLEAR NEUTROPHIL FUNCTION, BACTERIAL CLEARANCE, AND LUNG HISTOLOGY IN ENDOTOXEMIAShock, 2008
- The immune response to fungal infectionsBritish Journal of Haematology, 2005
- EFFECTS OF HIGH-DOSE OF INTRAVENOUS IMMUNOGLOBULIN AND ANTIBIOTICS ON SURVIVAL FOR SEVERE SEPSIS UNDERGOING SURGERYShock, 2005
- Clinical Microbiology of Bacterial and Fungal Sepsis in Very-Low-Birth-Weight InfantsClinical Microbiology Reviews, 2004
- Treatment of Gram-negative septic shock with an immunoglobulin preparationCritical Care Medicine, 1991
- Characteristics of pediatric intermediate care units in pediatric training programsCritical Care Medicine, 1991
- Immunologic basis for increased susceptibility of the neonate to infectionThe Journal of Pediatrics, 1986